Abstract
Rectal cancer (RC) management has changed dramatically over the last decade. Total mesorectal excision (TME) [1], performed with either an open or laparoscopic approach, is accepted worldwide as the standard surgical technique for cancer of the middle and lower rectum. Moreover, many randomized trials have clearly demonstrated that neoadjuvant therapy followed by surgery is superior to radical surgery alone and to postoperative chemoradiotherapy for locally advanced rectal cancer (TNM stage II–III) [2, 3]. With this approach, the 5-year local recurrence (LR) rates are reported to be <7%, and up to 20% of patients show pathological complete response (pCR). Patients with pCR show improved long-term outcomes compared with those with residual disease [4]. However, TME with preoperative chemoradiotherapy (PCRT) contributes to up to 6% of perioperative mortality [5], high rates of early and late complications, and bowel, urinary, and sexual dysfunction [6, 7]. Clinical TNM stage I RC is treated with TME alone, while locally advanced disease is usually treated with preoperative long-term radiotherapy concomitant with chemotherapy followed by TME.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Heald RJ, Husband EM et al (1982) The mesorectum in rectal cancer surgery–the clue to pelvic recurrence? Br J Surg 69:613–616
Sauer R, Becker H et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Eng J Med 351:1731–1740
Bosset JF, Collette L et al (2006) Chemotherapy with pre-operative radiotherapy in rectal cancer. N Eng J Med 355:1114–1123
Maas M, Nelemans PJ et al (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11:835–844
Paun BC, Cassie C et al (2010) Postoperative complications following surgery for rectal cancer. Ann Surg 251:807–818
Borowski DW, Bradburn DM (2010) Volume-outcome analysis of colorectal cancer-related outcomes. Northern Region Colorectal Cancer Audit Group (NORCCAG). Br J Surg 97:1416–1430
Pucciarelli S, Gagliardi G et al (2009) Long-term oncologic results and complications after preoperative chemoradiotherapy for rectal cancer: a single-institution experience after a median follow-up of 95 months. Ann Surg Oncol 16:893–899
You YN, Baxter NN et al (2007) Is the icreasing rate of local excision for stage I rectal cancer in the United States justified? A nationwide cohort study from national cancer database. Ann Surg 245:726–733
Bentrem DJ, Okabe S et al (2005) T1 adenocarcinoma of the rectum. Transanal excision of radical surgery? Ann Surg 242:472–479
Nascimbeni R, Burgart LJ et al (2002) Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 45:200–206
Gopaul D, Belliveau P et al (2004) Outcome of local excision of rectal carcinoma. Dis Colon Rectum 11:1780–1788
Kajiwara Y, Ueno H et al (2010) Risk factors of nodal involvement in T2 colorectal cancer. Dis Colon Rectum 53:1393–1399
Fang WL, Chang SC et al (2005) Metastatic potential in T1 and T2 colorectal cancer. Hepatogastroenterolgy 52:1688–1691
Bosch SL, Taerenstra S et al (2013) Predicting lymph metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions. Endoscopy 45:827–834
Heafner TA, Glasgow SC (2014) A critical review of the role of local excision in the treatment of early (T1 and T2) rectal tumors. J Gastrointest Oncol 5:345–352
Garcia-Aguilar J, Mellgren A et al (2000) Local excision of rectal cancer without adjuvant therapy a word of caution. Ann Surg 231:345–351
Endreseth BH, Myrvold HE et al (2005) Transanal excision vs. major surgery for T1 rectal cancer. Dis Colon Rectum 48:1380–1388
Nash GM, Weiser MR et al (2009) Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum 52:345–351
Doornebosch PG, Ferenschild FT et al (2010) Treatment of recurrence after transanal endoscopic microsurgery (TEM) for T1 rectal cancer. Dis Colon Rectum 53:1234–1239
Blumberg D, Paty PB et al (1999) All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum 42:881–885
Kikuchi R, Takano M et al (1995) Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 38:1286–1289
Chang AJ, Nahas CS et al (2008) Early rectal cancer: local excision or radical surgery? J Surg Educ 65:67–72
Kidane B, Chadi SA et al (2015) Local resection compared with radical resection in the treatment of T1N0M0 rectal adenocarcinoma: a systematic review and meta-analysis. Dis Colon Rectum 58:122–140
Bhangu A, Brown G et al (2013) Survival outcome of local excision versus radical resection of colon or rectal carcinoma. Ann Surg 258:563–571
Read TE, Andujar JE et al (2004) Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum 47:825–831
Pucciarelli S, Capirci C et al (2005) Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg Oncol 12:111–116
Park IJ, You YN (2013) Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum 56:135–141
Habr-Gama A, Perez RO et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long term results. Ann Surg 240:711–717
Habr-Gama A, de Souza PM et al (1998) Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 41:1087–1096
Habr-Gama A, Perez RO et al (2005) Long term results of preoperative chemoradiation for distal rectal cancer: correlation between final stage and survival. J Gastrointest Surg 9:90–109
Habr-Gama A, Perez RO et al (2006) Patterns of failure and survival for non-operative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 2006 10:1319–1328
Habr-Gama A, Perez RO et al (2011) Nonoperative approaches to rectal cancer: a critical evaluation. Semin Radiat Oncol 21:234–249
Habr-Gama A, Gama-Rodriguez J et al (2014) Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiation Oncol Biol Phys 88:822–828
Maas M, Beets-Tan RG et al (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29:4633–4640
Hughes R, Harrison M et al (2010) Could wait and see policy br justified in T3/4 rectal cancer after chemo-radiotherapy? Acta Oncol 49:378–381
Dalton R, Velineni R et al (2012) A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management? Colorectal Dis 29:567–571
Kim CJ, Yeatman TJ et al (2001) Local excision of T2 and T3 rectal cancer after downstaging chemoradiation. Ann Surg 234:352–358
Schell SR, Zlotecki RA et al (2002) Transanal excision of locally adavanced rectal cancer downstaged using neoadjuvant chemoradiotherapy. J Am Coll Surg 194:584–590
Lezoche E, Guerrieri M et al (2002) Long-term results of patients with pT2 rectal cancer treated with radiotherapy and transanal endoscopic microsurgical excision. World J Surg 26:1170–1174
Callender GG, Das P et al (2010) Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol 17:441–447
Coco C, Rizzo G et al (2013) Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. Surg Endosc 27:2860–2867
Lezoche E, Baldarelli M et al (2012) Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal ecxision for T2 rectal cancer after neoadjuvant therapy. Br J Surg 99:1211–1218
Garcia-Aguilar J, Shi Q et al (2012) A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol 19:384–391
Pucciarelli S, De Paoli A et al (2013) Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial. Dis Colon Rectum 56:1349-1356
Bujko K, Richter P et al (2013) Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders: a prospective multicentre study. Radiother Oncol 106:198–205
Shaikh I, Askari A et al (2015) Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 30:19–29
Zhao RS, Wang H et al (2014) Restaging of locally advanced rectal cancer with magnetic resonance imaging and endoluminal ultrasound after preoperative chemoradiotherapy: a systemic review and meta-analysis. Dis Colon Rectum 57:388–395
Glynne-Jones R, Hughes R (2012) Critical appraisal of the “wait and see” approach in rectal cancer for clinical complete responders after chemoradiatio. Br J Surg 99:897–909
Smith FM, Wiland H et al (2014) Clinical criteria understimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy. Dis Colon Rectum 57:311–315
Maretto I, Pomerri F et al (2007) The potential of restaging in the prediction of pathological response after preoperative cheradiotherapy for rectal cancer. Ann Surg Oncol 14:455–461
Perez RO, Habr-Gama A et al (2012) Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can the rule out persisting cancer? Colorectal Dis 14:714–720
Marijnen CA (2015) Organ preservation in rectal cancer: have all questions been answered? Lancet Oncol 16:13–22
Friel CM, Cromwell JW (2002) Salvage radical surgery after failed local excision for early rectal cancer. Dis Colon Rectum 45:875–879
Weiser MR, Landmann RG et al (2005) Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum 48:1169–1175
You YN, Roses RE et al (2012) Multimodality salvage of recurrent disease after local excision for rectal cancer. Dis Colon Rectum 55:1213–1219
Bikhchandani J, Ong GK et al (2015) Outcomes of salvage surgery for cure in patients with locally recurrent disease after local excision of rectal cancer. Dis Colon Rectum 58:283–288
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Italia
About this chapter
Cite this chapter
Pucciarelli, S., Barina, A., Rella, A. (2016). Local Failure After Conservative Treatment of Rectal Cancer. In: Romano, G.M. (eds) Multimodal Treatment of Recurrent Pelvic Colorectal Cancer. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5767-8_14
Download citation
DOI: https://doi.org/10.1007/978-88-470-5767-8_14
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5766-1
Online ISBN: 978-88-470-5767-8
eBook Packages: MedicineMedicine (R0)